 |
|
Pharmacology of Propylthiouracil in Thyrotoxicosis and Chronic Renal Failure
David S. Cooper, MD;
Susan Steigerwalt, MD;
Steven Migdal, MD
Arch Intern Med. 1987;147(4):785-786.
Abstract
• The simultaneous occurrence of thyrotoxicosis and renal failure has rarely been reported in the literature, and data concerning appropriate antithyroid drug management in this circumstance are limited. We studied propylthiouracil pharmacokinetics in one such patient basally and while the patient was receiving hemodialysis. On a day when the patient was not receiving hemodialysis, propylthiouracil serum levels were high, but serum propylthiouracil half-life was not prolonged. During hemodialysis, serum propylthiouracil levels were normal, and the time to peak serum levels was delayed; the disappearance of the drug from the serum was normal after hemodialysis was completed. The amount of propylthiouracil that appeared in the dialysate was approximately 5% of the administered dose. These data suggest that propylthiouracil can be administered in standard dosages to patients with thyrotoxicosis and renal failure.
(Arch Intern Med 1987;147:785-786)
Author Affiliations
From the Endocrine Divisions, Sinai Hospital of Baltimore and The Johns Hopkins University School of Medicine, Baltimore (Dr Cooper); the Division of Nephrology, Henry Ford Hospital, Detroit (Dr Steigerwalt); and the Nephrology Divisions, Wayne State University School of Medicine and Hutzel Hospital, Detroit (Dr Migdal).
Footnotes
Accepted for publication Oct 24, 1986.
Reprint requests to the Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Belvedere and Greenspring Avenues, Baltimore, MD 21215 (Dr Cooper).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Masked hyperthyroidism in a haemodialysis patient successfully treated by potassium iodide
Sanai et al.
Clin Kidney J 2012;0:sfr173v1-sfr173.
FULL TEXT
Carbimazole therapy in the setting of end-stage renal disease and haemodialysis
Varughese et al.
Nephrol Dial Transplant 2006;21:2318-2319.
FULL TEXT
|
